Moreover, the results also indicated that the upregulated SPRY4-IT1 expression may be closely relevant to poor overall survival in clear cell renal cell carcinoma and glioma (P < 0.001), which partially confirmed our results in this meta-analysis (Figure 5). The gene discussed is SPRY4; the disease is central nervous system cancer.